Natural Health Trends Corp

Natural Health Trends Corp(NHTC)の株式分析

$0.764

-0.076 (-9.99%)終値時点

Loading chart…
高値
0.870
始値
0.856
出来高加重平均価格
0.78
出来高
129.04K
時価総額
81.08M
安値
0.700
売買代金
100.39K
EV/EBITDA(TTM)
0.00

Natural Health Trends Corp. is a direct-selling and e-commerce company. The Company offers a line of NHT Global branded products in categories which include wellness, herbal, beauty, lifestyle and at-home tests. Its wellness products are formulated and designed to meet specific wellness goals, which include nutrition for joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health. Its beauty product line includes age-defying and hydrating cleansers, creams, lotions, serums and toners to moisturize, protect and improve the appearance of skin. Its lifestyle products support active, physical and healthy lifestyles, including weight management, and energy-enhancing supplements. Its wellness products include Triotein, Cluster X2, ReStor Silver, and Glucosamine 2200. Its herbal products include LivaPro, Cordyceps Mycelia CS-4, and RespFactor. Its beauty products include Skindulgence Essence Gel, Floraeda Toner and Primer.

AI分析 of Natural Health Trends Corp (NHTC)

中立

Natural Health Trends Corp (NHTC) is not a strong buy at this moment due to its current price of 0.7642, which is close to its 52-week low of 0.70, indicating a lack of upward momentum. The RSI is at 38.098, suggesting that the stock is nearing oversold territory but has not yet shown signs of a reversal. Additionally, the forward P/E ratio is 13.44, which is reasonable, but the company has reported a significant year-to-date change of -75.19%, reflecting ongoing challenges in revenue generation and profitability. The main risk is the declining net income, which has been negative for the last three quarters, with the latest reported net income of -232,000 USD in Q3 2026.

バリュエーション指標

Natural Health Trends Corp(NHTC)の現在の予想PERは13.44で、5年平均は2.59です。

予想PER

割高
5年平均 P/E
2.59
現在のP/E
13.44
割高
8.48
割安
-3.30

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
0.00
現在のEV/EBITDA
0.00
割高
0.00
割安
0.00

予想PSR

大幅な割安
5年平均 P/S
0.00
現在のP/S
0.00
割高
0.00
割安
0.00

Alphio AI による NHTC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%NHTC

$5.32

シナリオ価格

基

基本

基本 · 50%NHTC

$4.76

シナリオ価格

弱

弱気

弱気 · 25%NHTC

$4.39

シナリオ価格

イベントタイムライン

2026-02-17 (ET)

16:50:00

Natural Health Repurchases Shares from George K. Broady Family for $5.9M

2026-02-04 (ET)

09:10:00

Natural Health Trends Corp Q4 Revenue at $9.7M

2025-11-05 (ET)

09:03:54

Natural Health Trends announces Q3 EPS of 4 cents compared to 0 cents in the previous year.

2025-07-30 (ET)

09:02:00

Natural Health Trends reports Q2 EPS 0c vs 2c last year

2025-04-30 (ET)

09:07:07

Natural Health Trends reports Q1 EPS 1c vs 2c last year

ニュース

NHTC のよくある質問 — Alphio AI が回答

Natural Health Trends Corp. is a direct-selling and e-commerce company. The Company offers a line of NHT Global branded products in categories which include wellness, herbal, beauty, lifestyle and at-home tests. Its wellness products are formulated and designed to meet specific wellness goals, which include nutrition for joint health, antioxidant support, digestive health, heart health, vision health, immune support and cellular health. Its beauty product line includes age-defying and hydrating cleansers, creams, lotions, serums and toners to moisturize, protect and improve the appearance of skin. Its lifestyle products support active, physical and healthy lifestyles, including weight management, and energy-enhancing supplements. Its wellness products include Triotein, Cluster X2, ReStor Silver, and Glucosamine 2200. Its herbal products include LivaPro, Cordyceps Mycelia CS-4, and RespFactor. Its beauty products include Skindulgence Essence Gel, Floraeda Toner and Primer. It operates in the Consumer Cyclicals sector (WHOLESALE-MISCELLANEOUS NONDURABLE GOODS industry).

Natural Health Trends Corp (NHTC) is not a strong buy at this moment due to its current price of 0.7642, which is close to its 52-week low of 0.70, indicating a lack of upward momentum. The RSI is at 38.098, suggesting that the stock is nearing oversold territory but has not yet shown signs of a reversal. Additionally, the forward P/E ratio is 13.44, which is reasonable, but the company has reported a significant year-to-date change of -75.19%, reflecting ongoing challenges in revenue generation and profitability. The main risk is the declining net income, which has been negative for the last three quarters, with the latest reported net income of -232,000 USD in Q3 2026.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める